Literature DB >> 28363780

miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.

Azam Ahmadi1, Behzad Khansarinejad2, Saman Hosseinkhani3, Mostafa Ghanei4, Seyed Javad Mowla5.   

Abstract

INTRODUCTION: Non-small cell lung cancer (NSCLC) is the most common subtype of lung cancer. One of the signal transduction pathways related to NSCLC is Unfolded Protein Response (UPR), which is mainly regulated by GRP78 (HSPA5, Gene ID: 3309). The aim of this study was to employ bioinformatics tools to predict microRNAs (miRNAs) affecting GRP78 expression, experimentally validate interaction of these miRNAs with GRP78 and also evaluating the expression correlation of GRP78 and its predicted miRNAs in clinical samples.
MATERIALS AND METHODS: Various software were used to predict miRNAs that simultaneously target all upstream and downstream components of GRP78 in the UPR, as well as the main components of PI3K/AKT, MAPK, ErbB and calcium pathways. For experimental analysis, 36 pairs of Formalin-Fixed Paraffin-Embedded (FFPE) lung tumor and non-tumor tissue samples were obtained. Additionally, A549 and QU-DB lung cancer cell lines were used for expression determination of GRP78 and its predicted targeting miRNAs. We also employed a luciferase assay to evaluate interactions between candidate miRNAs with the 3'-UTR of GRP78.
RESULTS: hsa-miR-495 and hsa-miR-199-5p were chosen based on several criteria including thermodynamic binding features of miRNAs to the target transcripts, number of recognition sites, and conservation of binding sites within the 3'-UTR of GRP78. RT-qPCR data revealed a significant up-regulation of GRP78 (3.87 times, P=0.002) and down-regulation of miR-199a-5p (0.13 times, P=0.0001) and miR-495 (0.085 times, P=0.0001) in tumor samples. Luciferase assay confirmed an interaction of hsa-miR-199a-5p and hsa-miR-495 with the 3'-UTR of GRP78 transcript. In addition, over-expression and competitive inhibition of the aforementioned miRNAs, significantly altered the expression of GRP78 and spliced XBP1 level.
CONCLUSION: Our data revealed a significant up-regulation of GRP78 and a concomitant down-regulation of miR-495 and miR-199a-5p in NSCLC. Accordingly, our data suggest a causative role for miR-199-5p and miR-495 in tumorgenesis of lung and probably other cancer types.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GRP78; Luciferase assay; Non-small cell lung cancer; UPR

Mesh:

Substances:

Year:  2017        PMID: 28363780     DOI: 10.1016/j.gene.2017.03.032

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  25 in total

1.  MiR-495 regulates macrophage M1/M2 polarization and insulin resistance in high-fat diet-fed mice via targeting FTO.

Authors:  Fang Hu; Jingkai Tong; Bangli Deng; Jia Zheng; Chengzhi Lu
Journal:  Pflugers Arch       Date:  2019-11-11       Impact factor: 3.657

Review 2.  Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention.

Authors:  Zahra Fathi; Nicholas L Syn; Jian-Guo Zhou; Raheleh Roudi
Journal:  J Hum Genet       Date:  2018-04-18       Impact factor: 3.172

3.  miR-495 Regulates Cellular Reactive Oxygen Species Levels by Targeting sod2 To Inhibit Intracellular Survival of Mycobacterium tuberculosis in Macrophages.

Authors:  Xuanxiu Ren; Wenqi Dong; Jiajia Feng; Pei Li; Yucheng Zheng; Gaoyan Wang; Wenjia Lu; Xiangru Wang; Huanchun Chen; Chen Tan
Journal:  Infect Immun       Date:  2021-09-20       Impact factor: 3.441

4.  SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.

Authors:  Rafal Bartoszewski; Michal Dabrowski; Bogdan Jakiela; Sadis Matalon; Kevin S Harrod; Marek Sanak; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 5.464

5.  PERK-mediated induction of microRNA-483 disrupts cellular ATP homeostasis during the unfolded protein response.

Authors:  Nobuhiko Hiramatsu; Karen Chiang; Cathrine Aivati; Jeffrey J Rodvold; Ji-Min Lee; Jaeseok Han; Leon Chea; Maurizio Zanetti; Edward H Koo; Jonathan H Lin
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

Review 6.  Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer.

Authors:  Kentaro Inamura
Journal:  Cancers (Basel)       Date:  2017-05-09       Impact factor: 6.639

7.  Exploring the tissue tropism of pseudorabies virus based on miRNA level analysis.

Authors:  Yi Fan; Ling Zhu; Xiangang Sun; Wenting Lyu; Lei Xu; Yue Yin; Jun Zhao; Jianbo Huang; Yichao Den; Zhiyi Jiang; Shiyao Xu; Xiyu Mao; Zhiwen Xu
Journal:  BMC Microbiol       Date:  2019-06-11       Impact factor: 3.605

8.  Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.

Authors:  Zhiguo Zhu; Yaoan Wen; Chunxiang Xuan; Qingping Chen; Qian Xiang; Jiamin Wang; Yangzhou Liu; Lianmin Luo; Shankun Zhao; Yihan Deng; Zhigang Zhao
Journal:  FEBS Open Bio       Date:  2020-03-19       Impact factor: 2.693

9.  HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer.

Authors:  Guangyu Gao; Jiaofeng Shen; Xinya Shi
Journal:  Onco Targets Ther       Date:  2021-06-25       Impact factor: 4.345

10.  miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.

Authors:  Xueping Feng; Wuwu Lv; Shuanglian Wang; Qian He
Journal:  Oncol Rep       Date:  2018-07-02       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.